Megan Sniecinski - Net Worth and Insider Trading
Megan Sniecinski Net Worth
The estimated net worth of Megan Sniecinski is at least $351,900 dollars as of 2024-11-13. Megan Sniecinski is the Chief Business Officer of BioCryst Pharmaceuticals Inc and owns about 45,000 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $351,900. Details can be seen in Megan Sniecinski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Megan Sniecinski has not made any transactions after 2019-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Megan Sniecinski
Megan Sniecinski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Megan Sniecinski owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Megan Sniecinski’s form 4 insider trades.
Insider Ownership Summary of Megan Sniecinski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2019-11-18 | Chief Business Officer |
Megan Sniecinski Latest Holdings Summary
Megan Sniecinski currently owns a total of 1 stock. Megan Sniecinski owns 45,000 shares of BioCryst Pharmaceuticals Inc (BCRX) as of November 18, 2019, with a value of $351,900.
Latest Holdings of Megan Sniecinski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2019-11-18 | 45,000 | 7.82 | 351,900 |
Holding Weightings of Megan Sniecinski
Megan Sniecinski Form 4 Trading Tracker
According to the SEC Form 4 filings, Megan Sniecinski has made a total of 1 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 45,000 shares on November 18, 2019, which cost Megan Sniecinski around $65,250.
Insider Trading History of Megan Sniecinski
- 1
Megan Sniecinski Trading Performance
GuruFocus tracks the stock performance after each of Megan Sniecinski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Megan Sniecinski is 72.06%. GuruFocus also compares Megan Sniecinski's trading performance to market benchmark return within the same time period. The performance of stocks bought by Megan Sniecinski within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Megan Sniecinski's insider trading performs compared to the benchmark.
Performance of Megan Sniecinski
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 85.88 | | | | | |
| Relative Return to S&P 500(%) | 83.67 | | | | | |
Megan Sniecinski Ownership Network
Ownership Network List of Megan Sniecinski
Ownership Network Relation of Megan Sniecinski
Megan Sniecinski Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Megan Sniecinski is the Chief Business Officer of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Megan Sniecinski made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 8,689 shares made by Machelle Sanders , a net sale of 7,866 shares made by Nancy J Hutson , and a net purchase of 36,300 shares made by Anthony Doyle .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 146,748 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Megan Sniecinski Mailing Address
Above is the net worth, insider trading, and ownership report for Megan Sniecinski. You might contact Megan Sniecinski via mailing address: 4505 Emperor Blvd., Suite 200, Durham Nc 27703.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
